Terapias dirigidas en amiloidosis cardÃaca por transtiretina: una revisión del contexto clÃnico contemporáneo
Arch Cardiol Mex. 2025 Dec 3. doi: 10.24875/ACM.25000099. Online ahead of print.ABSTRACTTransthyretin cardiac amyloidosis is a recently recognized disease, still significantly underdiagnosed. It is characterized by infiltration of amyloid proteins resulting from the destabilization of the transthyre

